Your Next Pain Prescription Could Come without Addiction Risk
60-Second Science sciam.com
This is what was read here when it was published. Scientific American no longer carries it in what it publishes now.
The Food and Drug Administration has granted priority review to suzetrigine, a novel painkiller. It’s part of a new class of medications that could provide relief to those with chronic pain. The drugs target sodium channels on nerve cells, stopping pain signaling at the periphery. Journalist Marla Broadfoot explains the biology of aches and pains and the reasons it is so challenging to develop well-tolerated medications for pain.
New Painkiller Could Bring Relief to Millions—Without Addiction Risk
More ways to use this
Open on another device
Scan to open this page. Your saved notes and account access are not included.